Advanced Strategies for Hypothyroidism, Hashimoto’s Disease, and Personalized Thyroid Therapies
Drawing on decades of combined clinical experience, our panel of experts examines why many patients remain symptomatic despite “normal” laboratory results, and explains how a comprehensive evaluation—including clinical presentation, advanced thyroid testing, and individualized therapies—can lead to desired patient outcomes. The discussion also explores the growing role of low dose naltrexone (LDN) as an adjunctive therapy for autoimmune thyroid disease and chronic inflammation.
In this Preferred Provider webinar, Belmar Pharma Solutions Medical Director, Angela DeRosa, DO, MBA, CPE, and Vice President of Product Management, Samantha Lebsock, PharmD, have an in-depth discussion about the diagnosis and management of hypothyroidism, Hashimoto’s thyroiditis, and personalized thyroid therapy.
What You’ll Learn About Thyroid Conditions & Therapies
Our clinical experts review the physiology of thyroid hormone production and conversion, highlighting the importance of looking beyond TSH and free T4 to include free T3, reverse T3, thyroid antibodies, and the patient’s overall clinical picture.
Learn how to identify common signs and symptoms of hypothyroidism; recognize the impact of stress, inflammation, nutrition, and hormonal changes on thyroid function; and better understand the relationship between Hashimoto’s disease and autoimmune dysfunction. The webinar also covers the mechanisms, dosing strategies, and clinical benefits of low dose naltrexone for patients with Hashimoto’s thyroiditis, including practical guidance for monitoring and adjusting therapy over time.
Practical Guidance for Personalized Thyroid Care
Throughout the webinar, our panel of experts shares practical strategies for selecting appropriate thyroid replacement therapies, including:
- Levothyroxine
- Liothyronine (T3)
- Desiccated thyroid
- Compounded thyroid medications
The discussion addresses the advantages of customized dosing, modified-release formulations, and individualized T3 combinations, as well as current regulatory developments affecting desiccated thyroid products. Providers will also gain practical insights into interpreting thyroid laboratory values, managing complex patient presentations, monitoring therapy, and integrating personalized medicine into everyday clinical practice.
Whether you are new to thyroid management or looking to refine your approach to addressing hypothyroidism and Hashimoto’s disease, this webinar provides evidence-informed guidance to help you confidently address and personalize therapies with the goal of improving long-term patient wellness.
Watch on-demand today.
This webinar is intended for providers. If you are a provider and would like to watch the webinar, please fill out the form below.
